Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,956 public trials 647 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Completed

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

NCT01576666

Conditions
Advanced Pancreatic Adenocarcinoma, Advanced Solid Tumors, Astrocytoma, +35 more
Locations
  • Cedars Sinai Medical Center SC Los Angeles, California, United States
  • University of California San Francisco UCSF (SC) San Francisco, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • Dana Farber Cancer Institute Dana SC Boston, Massachusetts, United States
View all 23 locations
View Trial Details
Completed

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

NCT01324479

Conditions
Astrocytoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of Chicago SC Chicago, Illinois, United States
  • Karmanos Cancer Institute Wayne St Karmanos Detroit, Michigan, United States
  • Sarah Cannon Research Institute Dept of Onc Nashville, Tennessee, United States
View all 47 locations
View Trial Details
Completed

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

NCT00880308

Conditions
Advanced Solid Tumor Cancers, Basal Cell Carcinoma, Carcinoma, +12 more
Locations
  • University of Pittsburgh Medical Center SC Pittsburgh, Pennsylvania, United States
  • Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5) San Antonio, Texas, United States
  • Novartis Investigative Site Barcelona, Catalonia, Spain
  • Novartis Investigative Site Zurich, Switzerland
View Trial Details
Completed

An East Asian Study of LDE225

NCT01208831

Conditions
Advanced Solid Tumor Cancers, Basal Cell Carcinoma, Carcinoma, +12 more
Locations
  • Novartis Investigative Site Hong Kong
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kobe, Hyōgo, Japan
  • Novartis Investigative Site Taipei, Taiwan
View Trial Details
Completed

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

NCT01106508

Conditions
Advanced Solid Tumors, Carcinoma, Carcinoma, Basal Cell, +17 more
Locations
  • University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Novartis Investigative Site Utrecht, Netherlands
  • Novartis Investigative Site Zurich, Switzerland
View Trial Details

Related conditions